Sage Journals: Discover world-class research

Abstract

BACKGROUND:

World Health Organization statistics identifies that there are about 150 million people with diabetes mellitus worldwide and suggest that this figure may double by 2025.

OBJECTIVE:

This research was conducted to determine the status of full blood count, zinc and manganese levels among Diabetic patients attending Specialist Hospital, Sokoto.

METHODS:

The participants were divided into two groups; 58 diabetic subjects and 29 non-diabetic controls. Five milliliters of blood were collected into EDTA and plain containers for full blood count, serum zinc and manganese analysis. The FBC investigation was carried out using automated Mythic Haematology analyzer (Orphee, Switzerland) while Zn and Mn investigations were carried out using Atomic Absorption Spectrometry (AAS). The FBC, Zn and Mn status of both control and subjects were compared statistically.

RESULTS:

The results obtained in this study showed a significant increase in RBC, PCV, Hb, Basophils, Eosinophil, Lymphocyte count and Manganese levels of diabetic subjects ( $p\leqslant$ 0.05) when compared with controls. There was no statistically significant difference in the other FBC parameters and Zinc levels between diabetic subjects and non-diabetic controls ( $p>$ 0.05). There was a statistically significant difference in the Hb, PCV and lymphocyte of diabetic patients based on gender ( $p<$ 0.05). FBC, Manganese and Zinc have no effect based on age group, while other socio-demographic factors also have no effect on the FBC, Manganese and Zinc parameters of diabetic patients. The study also showed no statistical difference in the FBC, Manganese and Zinc of smokers and non-smokers ( $p>$ 0.05, respectively). In conclusion, this research shows that some haematological parameters (RBC count, Basophils, Eosinophil, Lymphocyte, Hb and Manganese) of the diabetic patients are significantly higher compared to non-diabetic controls. Marital status had a significant effect on the Hb, PCV and Lymphocyte of the diabetic patients ( $p<$ 0.05). The age group had no significant effect on the Hb, PCV and Lymphocyte of diabetic subjects ( $p>$ 0.05).

CONCLUSIONS

There is need to routinely monitor the full blood count, zinc and manganese levels among diabetic subjects in the area to optimize the care offered to these patients.

Keywords

Haematological parameters manganese zinc levels diabetic patients specialist hospital Sokoto Nigeria

Get full access to this article

View all access options for this article.

References

World Health Organization (WHO). Global Report on Diabetes, 2016.

International Diabetes Federation (IDF). Diabetes Atlas, Sixth Edition (2013), p56.

Cooke

D.W.

and Plotnick

, Type 1 diabetes mellitus in pediatrics, Pediatric Review 29(11) (2008), 374–384.

Gaziano

T.A.

et al., Growing epidemic of coronary heart disease in low- and middle-income countries, Curr Probl Cardiol 35(2) (2010), 72–115.

Wild

et al., Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030, Diabetes Care 27(5) (2004), 1047–1053.

Khuwaja

A.K.

Khowaja

L.A.

and Cosgrove

, The economic costs of diabetes in developing countries: Some concerns and recommendations, Diabetologia 53 (2010), 389.

Mohammed

et al., Effects of Saqueous leaves extract of Ocimum gratissimum on blood glucose levels of streptozotocininduced diabetic Wistar rats, African Journal of Biotechnology 6 (2007), 2087–2090.

Ayepola

O.R.

Brooks

N.L.

and Oguntibeju

O.O.

, Oxidative stress and diabetic complications: The role of antioxidant vitamins and flavonoids. Retrieved from https://www.intechopen.com/books/antioxidant-antidiabetic-agents-and-human-health/oxidative-stress-and-diabetic-complications-the-role-of-antioxidant-vitamins-and-flavonoids (2014).

Reinehr

, Type 2 diabetes mellitus in children and adolescents, World J Diabetes 4(6) (2013), 270–281.

10.

Gheith

et al., Diabetic kidney disease: Worldwide difference of prevalence and risk factors, J Nephropharmacol 5(1) (2015), 49–56.

11.

Astor

B.C.

et al., Association of kidney function with anemia: the third national health and nutrition examination survey (1988–1994), Archives of Internal Medicine 162 (2002), 1401–1408.

12.

Dikow

Schwenger

and Schomig

, How should we manage anaemia in patients with diabetes? Nephrology Dialysis and Transplant 17 (2001), 67–72.

13.

Rob

, What is a normal full blood count? (Updated 14 september 2016) Available at: http://www.m.webmd.boots.com/a-to-z-guides/full-blood-count (2016).

14.

Mansi

and Lahham

, Effects of Artemisia sieberi Besser (a. herba-alba) on heart rate and some hematological values in normal and alloxan-induced diabetic rats, Journal for Advances in Sciences 12 (2008), 647–657.

15.

Al-Khoury

et al., Anaemia in diabetic patients with chronic kidney disease prevalence and predictors, Diabetologia 49 (2006), 1183–1189.

16.

Oyedemi

S.O.

Yakubu

M.T.

and Afolayan

A.J.

, Antidiabetic activities of aqueous leaves extract of Leonotis leonurus in streptozotocin induced diabetic rats, Journal of Medicinal Plant Research 5 (2011), 119–125.

17.

Dipta

T.F.

Quamrun

and Subhagata

, Pattern of haematological disorders in a tertiary diabetic hospital: A pilot study, Journal of Bangladesh College of Physicians and Surgeons 27 (2009), 148–154.

18.

Colak

et al., Effects of Lichen extracts on haematological parameters of rats with experimental insulin-dependent diabetes mellitus, Toxicology and Industrial Health 30(10) (2014), 878–887.

19.

Ruchi

and Pradeep

, A comparative study of haematological parameters in type 1 diabetes mellitus patients & healthy young adolescents, International Journal of Biological and Medical Research 3 (2012), 2429–2432.

20.

Thomas

and Rampersad

, Anaemia in diabetes, Acta Diabetologica 1 (2004), 13–17.

21.

Jaman

M.S.

et al., Diabetes and red blood cell parameters, Ann Clin Endocrinol Metabol 2 (2018), 001–009.

22.

Uko

E.K.

et al., Some Haematological Parameters in Patients with Type-1 Diabetes in Sokoto, North Western Nigeria, Journal of Blood Lymph 3 (2013), 1.

23.

Chung

F.M.

et al., Peripheral Total and Differential Leukocyte Count in Diabetic Nephropathy, Diabetes Care 28 (2005), 1710–1717.

24.

Ohshita

et al., Elevated white blood cell count in subjects with impaired glucose tolerance, Diabetes Care 27 (2004), 491–496.

25.

Ford

E.S.

, Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults, American Journal of Epidemiology 155 (2002), 57–64.

26.

Madjid

et al., Leukocyte count and coronary heart disease: Implications for risk assessment, Journal of the American College of Cardiology 44 (2004), 1945–1956.

27.

Olivares

Ducimetiere

and Claude

J.R.

, Monocyte count: a risk factor for coronary heart disease, American Journal of Epidemiology 137 (1993), 49–53.

28.

Haumer

et al., Association of neutrophils and future cardiovascular events in patients with peripheral artery disease, J Vasc Surg 41(4) (2005), 610–617.

29.

Goligorsky

M.S.

Chen

and Brodsky

, Endothelial cell dysfunction leading to diabetic nephropathy: focus on nitric oxide, Hypertension 37 (2000), 744–748.

30.

Nuhad

et al., Perspective in renal medicine: Renal disease and hypertension in non-insulin dependent diabetes mellitus, Kidney International 55 (1999), 1–28.

31.

Khalid

Nahla

and Salini

S.J.

, Variation in Macro and Trace Elements in Progression of Type 2 Diabetes, The Scientific World Journal (2014), 461591.

32.

Madjid

and Fatemi

, Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update, Tex Heart Inst J 40(1) (2013), 17–29.

33.

Lobene

A.J.

et al., Zinc Supplementation Does Not Alter Indicators of Insulin Secretion and Sensitivity in Black and White Female Adolescents, J Nutr 147(7) (2017), 1296–1300.

34.

Wallace

J.J.

, Management of diabetes in elderly, Clinical Diabetes 17 (2004), 1.

35.

Barrett

E.J.

et al., Diabetic microvascular disease: An endocrine society scientific statement, J Clin Endocrinol Metab 102(12) (2017), 4343–4410.

36.

NPC/FGN, Nigerian Population Commission, Federal Republic of Nigeria. Special FGN Gazette No. 23 on the 2006 Population Census (2006).

37.

Cochran

W.G.

, Sampling techniques (3rd edition). New York: John Wiley and Sons (1977).

38.

Thomas

and Rampersad

, Anaemia in diabetes, Acta Diabetologica 1 (2004), 13–17.

39.

Ruchi

and Pradeep

, A comparative study of haematological parameters in type 1 diabetes mellitus patients & healthy young adolescents, International Journal of Biological and Medical Research 3 (2012), 2429–2432.

40.

Taniguchi

et al., Platelet count is independently associated with insulin resistance in non-obese Japanese type 2 diabetic patients, Metabolism 52 (2003), 1246–1249.

41.

Schneider

D.J.

, Factors contributing to increased platelet reactivity in people with diabetes, Diabetes Care 32(4) (2009), 525–527.

42.

Sterner

Carlson

and Ekberg

, Raised platelet levels in diabetes mellitus complicated with nephropathy, Journal Internal Medicine 244 (1998), 437–441.

43.

Carobbio

et al., Leukocytosis and risk stratification assessment in essential thrombocythemia, Journal of Clinical Oncology 26 (2008), 2732–2736.

44.

Ezenwaka

C.E.

et al., Anaemia and kidney dysfunction in Caribbean type 2 diabetic patients, Cardiovascular Diabetology 7 (2008), 25.

45.

Eliasson

, Cigarette smoking and diabetes, Progress in Cardiovascular Diseases 45(5) (2003), 405–413.

Some haematological parameters,manganese and zinc levels among diabetic patients of African descent attending Specialist Hospital Sokoto,Nigeria